UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial

Journal of exposure science & environmental epidemiology, 2017-07, Vol.27 (4), p.444-450

2017

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study

Circulation (New York, N.Y.), 2013-12, Vol.128 (24), p.2567-2576

2013

Link zum Volltext

Verfügbarkeit prüfen

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

Therapeutic apheresis and dialysis, 2010-06, Vol.14 (3), p.276-286

2010

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Arteriosclerosis, thrombosis, and vascular biology, 2016-09, Vol.36 (9), p.2019

2016

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis

The American journal of cardiology, 2020-12, Vol.136, p.38-48

2020

Link zum Volltext

Verfügbarkeit prüfen

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis

Journal of clinical apheresis, 2020-06, Vol.35 (3), p.163-171

2020

Link zum Volltext

Verfügbarkeit prüfen

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

Pediatric nephrology (Berlin, West), 2018-07, Vol.33 (7), p.1199-1208

2018

Link zum Volltext

Verfügbarkeit prüfen

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

Journal of clinical apheresis, 2019-08, Vol.34 (4), p.423-433

2019

Link zum Volltext

Verfügbarkeit prüfen

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

European archives of oto-rhino-laryngology, 2009-07, Vol.266 (7), p.943-953

2009

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study

Clinical research in cardiology supplements, 2015-04, Vol.10 (Suppl 1), p.46-50

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Clinical research in cardiology supplements, 2017-03, Vol.12 (Suppl 1), p.38-43

2017

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and mortality—a high risk relationship

Clinical research in cardiology supplements, 2019-04, Vol.14 (Suppl 1), p.13-19

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial

Atherosclerosis. Supplements, 2015-05, Vol.18, p.35-40

2015

Link zum Volltext

Verfügbarkeit prüfen

Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – Perspectives for immunoadsorption

Atherosclerosis. Supplements, 2013-01, Vol.14 (1), p.161-165

2013

Link zum Volltext

Verfügbarkeit prüfen

Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis-Comparison of performance characteristics with DALI and lipidfiltration

Journal of clinical apheresis, 2007-01, Vol.22 (4), p.215-223

2007

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis

Atherosclerosis. Supplements, 2019-12, Vol.40, p.17-22

2019

Link zum Volltext

Verfügbarkeit prüfen

Determination of BOD-values of starch-containing waste water by a BOD-biosensor

Biosensors & bioelectronics, 1998-11, Vol.13 (10), p.1083-1090

1998

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange and immunoadsorption for autoimmune neurologic diseases – current guidelines and future perspectives

Atherosclerosis. Supplement (Amsterdam), 2009-12, Vol.10 (5), p.129-132

2009

Link zum Volltext

Verfügbarkeit prüfen

Determination of BOD-values of starch-containing waste water by a BOD-biosensor1This paper was presented at the fifth World Congress on Biosensors, Berlin, Germany, 3–5 June 1998.1

Biosensors & bioelectronics, 1998-11, Vol.13 (10), p.1083-1090

1998

Link zum Volltext

Verfügbarkeit prüfen

Rheopheresis for sudden sensorineural hearing loss

Atherosclerosis. Supplement (Amsterdam), 2009-12, Vol.10 (5), p.102-106

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Lipoprotein(a) and mortality—a high risk relationship

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial

Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – Perspectives for immunoadsorption

Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis-Comparison of performance characteristics with DALI and lipidfiltration

Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis

Determination of BOD-values of starch-containing waste water by a BOD-biosensor

Plasma exchange and immunoadsorption for autoimmune neurologic diseases – current guidelines and future perspectives

Determination of BOD-values of starch-containing waste water by a BOD-biosensor1This paper was presented at the fifth World Congress on Biosensors, Berlin, Germany, 3–5 June 1998.1

Rheopheresis for sudden sensorineural hearing loss

Suchergebnisse filtern